Leukocyte adhesion deficiency type II: Long-term follow-up and review of the literature

Journal of Clinical Immunology

Volumn 30, Issue 2, 2010, Pages 308-313

  Gazit, Yael ^a   Mory, Adi ^c   Etzioni, Amos ^c,d   Frydman, Moshe ^b,e   Scheuerman, Oded ^a,b   Gershoni Baruch, Ruth ^c,d   Garty, Ben Zion ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MEYER CHILDREN S HOSPITAL   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^e SHEBA MEDICAL CENTER   (Israel)

Author keywords

Adhesion defects; Fucose; Immunodeficiency; Neutrophilia; Selectins

Indexed keywords

ADULT; ARTICLE; AUTISM; CASE REPORT; CLINICAL FEATURE; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 2C; FOLLOW UP; GENETIC ANALYSIS; HUMAN; LEUKOCYTOSIS; MALE; MEDICAL LITERATURE; MENTAL DEFICIENCY; NEUTROPHILIA; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; SHORT STATURE;

ADULT; AUTISTIC DISORDER; CONSANGUINITY; DNA MUTATIONAL ANALYSIS; FETAL GROWTH RETARDATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISRAEL; LEUKOCYTE-ADHESION DEFICIENCY SYNDROME; MALE; MENTAL RETARDATION; MONOSACCHARIDE TRANSPORT PROTEINS; NEUTROPHILS; PEDIGREE; POINT MUTATION; POLYMORPHISM, GENETIC;

EID: 77953540247     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-009-9354-0     Document Type: Article

References (22)

1. Anderson DC, Smith CW. Leukocyte adhesion deficiencies. In: Scriver C, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited diseases. 8th ed. New York: McGraw-Hill; 2001. p. 4829-4856
2. Bauer TR, Allen JM, Hai M, Tuschong LM, Khan IF, Olson EM, et al. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vector. Nat Med. 2008;14:93-97
3. Yakubenia S, Wild MK. Leukocyte adhesion deficiency II advances and open questions. FEBS J. 2006;273:4390-4398
4. Marquardt T, Lühn K, Srikrishna G, Freeze HH, Harms E, Vestweber D. Correction of leukocyte adhesion deficiency type II with oral fucose. Blood. 1999;94:3976-3985
5. Etzioni A, Tonetti M, Vestweber D, Marquardt T. Fucose supplementation in leukocyte adhesion deficiency type II. Blood. 2000;95:3641-3643
6. Alon R, Etioni A. LAD III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol. 2003;24:561-566
7. Mory A, Feigelson SW, Yarali N, Kilic SS, Bayhon GI, Gershoni-Baruch R. Kindlin-3: a new gene involved in the pathogenesis of LAD III. Blood. 2008;112:2591.
8. Svensson L, Howarth K, McDowall A, Patzak I, Evans R, Ussar S, et al. Leukocyte adhesion deficiency III is caused by mutations in Kindlin3 affecting integrin activation. Nat Med. 2009;15:306-312
9. Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JR, et al. Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med. 1992;327(25):1789-1792
10. Frydman M, Etzioni A, Eidlitz-Markus T, Avidor I, Varsano I, Shechter Y, et al. Rambam-Hasharon syndrome of psychomotor retardation, short stature, defective neutrophil motility, and Bombay phenotype. Am J Med Genet. 1992;44:297-302.
11. Etzioni A, Sturla L, Antonellis A, Green ED, Gershoni-Baruch R, Berninsone PM, et al. Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG)IIc founder effect and genotype/phenotype correlation. Am J Med Genet. 2002;110:131-135
12. Marquardt T, Brune T, Lühn K, Zimmer KP, Korner C, Fahntz L, et al. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism. J Pediatr. 1999;134:681-688
13. Hidalgo A, Ma S, Peired AJ, Weiss LA, Cunningham-Rundles C, Frenette PS. Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene. Blood. 2003;101:1705-1712
14. Helmus Y, Denecke J, Yakubenia S, Robinson P, Luhn K, Watson DL, et al. Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter. Blood. 2006;107:3959-3966
15. Etzioni A, Gershoni-Baruch R, Pollack S, Shehadeh N. Leukocyte adhesion deficiency type II: long-term follow-up. J Allergy Clin Immunol. 1998;102:323-324
16. Frydman M, Vardimon D, Shalev E, Orlin JB. Prenatal diagnosis of Rambam-Hasharon syndrome. Prenat Diagn. 1996;16:266-269
17. Wild MK, Lühn K, Marquardt T, Vestweber D. Leukocyte adhesion deficiency II: therapy and genetic defect. Cells Tissues Organs. 2002;172:161-173
18. Lühn K, Marquardt T, Harm E, Vestweber D. Discontinuation of fucose therapy in LAD II causes rapid loss of selectin ligands and rise of leukocyte counts. Blood. 2001;97:330-332
19. Sturla L, Puglielli L, Tonetti M, Berninsone P, Hirschberg CB, De Fiora A, et al. Impairment of the Golgi GDP-L-fucose transport and unresponsiveness to fucose replacement therapy in LAD II patients. Pediatr Res. 2001;49(4):537-542
20. Aebi M, Helenius A, Schenk B, Barone R, Fiumara A, Berger EG, et al. Carbohydrate deficient glycoprotein syndrome becomes congenital disorder of glycosylation: an updated nomenclature for CDG. First International Workshop on CDGS. Glycoconj J. 1999; 16:669-671
21. Lübke T, Marquardt T, Etzioni A, Hartmann E, von Figura K, Körner C. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat Genet. 2001;28:73-76
22. Lühn K, Wild MD, Gerardy-Schahn R, Vestweber D. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat Genet. 2001;28:69-72.